5//SEC Filing
Q Therapeutics, Inc. 5
Accession 0001209191-16-098169
CIK 0001366541operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:19 PM ET
Size
5.1 KB
Accession
0001209191-16-098169
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
BORST STEVEN JOHN
CFO & VP of Corp. Development
Transactions
- Gift
Common Stock
2015-12-31+10,500→ 511,806 total(indirect: By Spouse)
Footnotes (1)
- [F1]Shares received as a gift.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 5
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:19 PM ET
- Size
- 5.1 KB